Registered Nurse in Fernley, NV Accepting Medicare
4 Registered Nurse nurses found. Showing 1 - 4
 Mrs. Cassandra Jo Peat, RN Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 555 E Main St, Fernley, NV 89408 Phone: 775-575-3363 Fax: 775-575-3364 |
Julie Marie Dums, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 555 E Main St, Fernley, NV 89408 Phone: 775-575-3363 Fax: 775-575-3364 |
Pam Ramirez, RN Registered Nurse - Psych/Mental Health Medicare: Not Enrolled in Medicare Practice Location: 415 Us Highway 95a S, Ste I 901, Fernley, NV 89408 Phone: 775-575-7744 Fax: 775-575-7769 |
Jackie Chapman, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 415 Highway 95a, Building I, Fernley, NV 89408 Phone: 775-575-7744 Fax: 775-575-7767 |
News Archive
Supreme Court declines to hear military medical malpractice case
The family of a young Navy nurse who died after military doctors allegedly failed to halt massive bleeding following childbirth won't get a hearing in the nation's highest court.
Artefill: First and only FDA-approved microsphere-enhanced dermal filler for correction of smile lines
Getting older is a fact of life. Looking older doesn't have to be. Patients now have a non-invasive treatment option to reduce the signs of aging and fight wrinkles for good - with no downtime. Known for their use of the latest technological advancements, Dr. Gilbert Lee and his team at Changes Plastic Surgery & Spa are now using Artefill, the first and only FDA-approved microsphere-enhanced dermal filler for the correction of smile lines, or the lines from your nose to the corners of your mouth.
New website and online store released by Advanced Cell Diagnostics
Advanced Cell Diagnostics Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based RNA analysis tools, has announced the launch of its new website, www.acdbio.com.
FDA grants Impax final approval for generic Allegra-D ANDA
Impax Laboratories, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted final approval of the Company's Abbreviated New Drug Application (ANDA) for the generic version of Allegra-D® (Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride Extended-release) 60mg/120mg tablets. The Company is preparing for product launch through Global Pharmaceuticals, Impax's generic division.
Quebec's first successful combined heart/liver transplant
Doctors at the McGill University Health Center have announced Quebec's first successful combined heart/liver transplant.
› Verified 4 days ago